LIVER FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND NONALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH OBESITY

LIVER FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND NONALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH OBESITY

LIVER FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND NONALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH OBESITY

Bibliographic Details
Main Authors:	O. Bondarenko, T. Maksymets, E. Sklyarov
Format:	Article
Language:	English
Published:	Shevchenko Scientific Society 2017-06-01
Series:	Праці Наукового товариства імені Шевченка. Медичні науки
Subjects:	obesity, coronary artery disease, statins, comorbide pathology
Online Access:	https://mspsss.org.ua/index.php/journal/article/view/75

Similar Items

Adropin and risk factors of arterial hypertension in patients with excess body weight and obesity
by: Nataliia Pokrovska, et al.
Published: (2022-11-01)

Beneficial effects of statins on adropin level in patients with arterial hypertension
by: N.K. Pokrovska, et al.
Published: (2023-02-01)

Multivariate prognosis of non-alcoholic fatty liver disease development in visceral obesity in patients with coronary artery disease and hypertension
by: I. V. Logacheva, et al.
Published: (2021-02-01)

Evaluation of the Correlation between Coronary Artery Disease and Nonalcoholic Fatty Liver Disease: Is There Any Correlation?
by: Zahra Momayez Sanat, et al.
Published: (2023-01-01)

Prescription and adherence to statins of patients with coronary artery disease and hypercholesterolemia
by: Mansur Antonio P., et al.
Published: (2001-01-01)

Nonalcoholic fatty liver disease and non-liver comorbidities
by: Richie Manikat, et al.
Published: (2023-02-01)

Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?
by: Fabio Nascimbeni, et al.
Published: (2018-02-01)

Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery Calcification
by: Chien-Chih Chen, et al.
Published: (2021-08-01)

Сlinical and hemodynamic characteristics and coronary blood flow in patients with chronic coronary artery disease and type 2 diabetes
by: B. U. Mardanov, et al.
Published: (2022-01-01)

Assessment of factors related to statin non-adherence in patients with established coronary artery disease: A single-center observational study
by: Tuba Özdemir, et al.
Published: (2017-12-01)

Effect of Alirocumab on Coronary Calcification in Patients With Coronary Artery Disease
by: Fei Gao, et al.
Published: (2022-05-01)

Pleiotropic effects of statins in treatment of generalized periodontitis in patients with coronary artery disease: clinical and experimental study (literature review)
by: O.I. Martovlos (Hodovana), et al.
Published: (2022-06-01)

Predictors of late complications after coronary artery bypass grafting in patients with stable coronary heart disease
by: O.J. Zharinov, et al.
Published: (2018-11-01)

The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study
by: Wen Dai, et al.
Published: (2021-08-01)

Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease
by: Babak Baharvand-Ahmadi, et al.
Published: (2016-09-01)

Effect of Statins on the Inflammatory Markers in Patients with Coronary Artery Disease
by: Sujatha Mahadevarao Premnath, et al.
Published: (2023-12-01)

Nonalcoholic fatty liver disease and outcomes in patients with acute coronary syndrome
by: El-Saied Shaheen
Published: (2018-01-01)

Comparison between obese and non-obese nonalcoholic fatty liver disease
by: Wah-Kheong Chan
Published: (2023-02-01)

Gut microbiota in obesity and nonalcoholic fatty liver disease
by: Lina Guo, et al.
Published: (2021-06-01)

Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography
by: Fei Gao, et al.
Published: (2021-09-01)

Outcome and Graft Patency in Coronary Artery Bypass Grafting with Coronary Endarterectomy
by: Mohammad Hassan Nemati, et al.
Published: (2015-02-01)

Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
by: Lu C, et al.
Published: (2023-08-01)

Obesity, Serum Resistin and Leptin Levels Linked to Coronary Artery Disease
by: Farzaneh Montazerifar, et al.

Obesity and nonalcoholic fatty liver disease: metabolic risks and their correction
by: Kseniya Andreevna Komshilova, et al.
Published: (2015-08-01)

Severity of Coronary Artery Disease associated with Non-Alcoholic Fatty Liver
by: Albair Abdulmaseh*, et al.
Published: (2021-01-01)

Comparison of Novel Coronary Artery Disease Risk Factors between Obese and Normal Adolescent
by: Samaneh Kouzehgaran, et al.
Published: (2015-07-01)

Coronary artery disease and non‐alcoholic fatty liver disease: Clinical correlation using computed tomography coronary calcium scans
by: Richard S Kirby, et al.
Published: (2021-03-01)

The Associations Between Abdominal Obesity and Coronary Artery Calcification in Chronic Kidney Disease Population
by: Liu PT, et al.
Published: (2024-02-01)

Treatment of nonalcoholic fatty liver disease
by: Paul Angulo, MD
Published: (2002-01-01)

MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosis
by: D. A. Yakhontov, et al.
Published: (2022-11-01)

A clinical case of new onset type 2 diabetes mellitus in a patient with coronary artery disease and obesity treated with atorvastatin
by: T.A. Maksymets, et al.
Published: (2018-02-01)

New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis
by: Georgiana-Diana Cazac, et al.
Published: (2022-08-01)

Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease
by: Fatema Abu Bakr Abdel-Moez, et al.
Published: (2019-01-01)

Nonalcoholic fatty liver disease without obesity: the problem to be solved
by: A O Bueverov, et al.
Published: (2017-12-01)

Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry
by: Ying Xian, et al.
Published: (2019-10-01)

Rare case of proximal coronary plaque regression after distal arterial grafting
by: George Jose Valooran, et al.
Published: (2016-09-01)

Essential Polyunsaturated Fatty Acids in Blood from Patients with and without Catheter-Proven Coronary Artery Disease
by: Chaoxuan Wang, et al.
Published: (2022-01-01)

The role of coronary artery calcium estimation in the primary prevention strategy for cardiovascular diseases
by: M. Yu. Kolesnyk
Published: (2023-10-01)

DYNAMICS OF CHARACTERISTICS OF THE GLYCEMICAL PROFILE OF PATIENTS WITH CORONARY HEART DISEASE AND OBESITY AFTER TREATMENT
by: Olga V. Gridneva
Published: (2023-09-01)

Oxidative stress is associated with not only coronary artery disease on statin therapy but also diabetes mellitus and hypertension
by: Ibrahim Halil Altiparmak, et al.
Published: (2016-03-01)